SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ye Zhao, Bing Yu, Xiangbing Mao, Jun He, Zhiqing Huang, Ping Zheng, Jie Yu, Guoquan Han, Xiaofang Liang, Daiwen Chen, Dietary vitamin D supplementation attenuates immune responses of pigs challenged with rotavirus potentially through the retinoic acid-inducible gene I signalling pathway, British Journal of Nutrition, 2014, 112, 03, 381

    CrossRef

  2. 2
    S. Yokoyama, S. Takahashi, Y. Kawakami, C. N. Hayes, H. Kohno, H. Kohno, K. Tsuji, Y. Aisaka, S. Kira, K. Yamashina, M. Nonaka, T. Moriya, M. Kitamoto, S. Aimitsu, T. Nakanishi, H. Kawakami, K. Chayama, Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial, Journal of Viral Hepatitis, 2014, 21, 5
  3. 3
    Maria Theodorou, Thomas Sersté, Marc Van Gossum, Stéphane Dewit, Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients, Clinical Nutrition, 2014, 33, 2, 274

    CrossRef

  4. 4
    Daniela Ivanova Gerova, Bistra Tzaneva Galunska, Irina Ivanova Ivanova, Iskren Andreev Kotzev, Trifon Georgiev Tchervenkov, Svetlozar Petrov Balev, Dobrin Avramov Svinarov, Prevalence of vitamin D deficiency and insufficiency in Bulgarian patients with chronic Hepatitis C viral infection, Scandinavian Journal of Clinical & Laboratory Investigation, 2014, 1

    CrossRef

  5. 5
    Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Chisa Kondo, Norio Itokawa, Ai Nakagawa, Satomi Hashimoto, Takeshi Fukuda, Yoko Matsushita, Yoshiyuki Narahara, Katsuhiko Iwakiri, Katsuhisa Nakatsuka, Chiaki Kawamoto, Choitsu Sakamoto, Serum 25-hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load, Hepatology Research, 2014, 44, 7
  6. 6
    Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hiroshi Abe, Chisa Kondo, Norio Itokawa, Ai Nakagawa, Katsuhiko Iwakiri, Chiaki Kawamoto, Yoshio Aizawa, Choitsu Sakamoto, Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C, Digestive and Liver Disease, 2014,

    CrossRef

  7. 7
    F. Finkelmeier, B. Kronenberger, V. Köberle, J. Bojunga, S. Zeuzem, J. Trojan, A. Piiper, O. Waidmann, Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma – a prospective cohort study, Alimentary Pharmacology & Therapeutics, 2014, 39, 10
  8. 8
    Gerome V. Escota, Sara Cross, William G. Powderly, Vitamin D and Calcium Abnormalities in the HIV-Infected Population, Endocrinology and Metabolism Clinics of North America, 2014,

    CrossRef

  9. 9
    Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Chisa Kondo, Norio Itokawa, Ai Nakagawa, Satomi Hashimoto, Takeshi Fukuda, Yoko Matsushita, Hideko Kidokoro, Yoshiyuki Narahara, Katsuhisa Nakatsuka, Katsuhiko Iwakiri, Chiaki Kawamoto, Choitsu Sakamoto, Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study, Hepatitis Monthly, 2013, 13, 12

    CrossRef

  10. 10
    Mattias Mandorfer, Thomas Reiberger, Berit A. Payer, Arnulf Ferlitsch, Florian Breitenecker, Maximilian C. Aichelburg, Barbara Obermayer-Pietsch, Armin Rieger, Michael Trauner, Markus Peck-Radosavljevic, Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV–hepatitis C virus coinfected patients, AIDS, 2013, 27, 2, 227

    CrossRef

  11. 11
    Adriaan J. Meer, Raoel Maan, Robert J. Knegt, Bart J. Veldt, Natural History of HCV-induced Liver Disease, Current Hepatitis Reports, 2013, 12, 4, 251

    CrossRef

  12. 12
    Adeeb H. Rahman, Andrea D. Branch, Vitamin D for your patients with chronic hepatitis C?, Journal of Hepatology, 2013, 58, 1, 184

    CrossRef

  13. 13
    Yuan-Ping Han, Ming Kong, Sujun Zheng, Yan Ren, Longdon Zhu, Hongbo Shi, Zhongping Duan, Vitamin D in liver diseases: From mechanisms to clinical trials, Journal of Gastroenterology and Hepatology, 2013, 28,
  14. 14
    P. Ameri, A. Giusti, M. Boschetti, M. Bovio, C. Teti, G. Leoncini, D. Ferone, G. Murialdo, F. Minuto, Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency, European Journal of Endocrinology, 2013, 169, 6, 767

    CrossRef

  15. 15
    Filomena Morisco, Annamaria Colao, Maria Guarino, Vincenzo Lembo, Rocco Granata, Laura Donnarumma, Francesco Auriemma, Anna Mariniello, Giovanna Mazzone, Carolina Di Somma, Manila Rubino, Federica Cariati, Claudia Pivonello, Ilaria Loperto, Nicola Caporaso, Vitamin D levels and chronic hepatitis C, e-SPEN Journal, 2013, 8, 4, e169

    CrossRef

  16. 16
    Takuya Matsumura, Takanobu Kato, Nao Sugiyama, Megumi Tasaka-Fujita, Asako Murayama, Takahiro Masaki, Takaji Wakita, Michio Imawari, 25-hydroxyvitamin D3 suppresses hepatitis C virus production, Hepatology, 2012, 56, 4
  17. 17
    Gerald M. Higa, Jason Hicks, Christopher Isabella, Adjudication of the Alleged Role of Vitamin D in the Antimicrobial Pathway, Scientifica, 2012, 2012, 1

    CrossRef

  18. 18
    Frank Grünhage, Katrin Hochrath, Marcin Krawczyk, Aksana Höblinger, Barbara Obermayer-Pietsch, Jürgen Geisel, Michael Trauner, Tilman Sauerbruch, Frank Lammert, Common genetic variation in vitamin D metabolism is associated with liver stiffness, Hepatology, 2012, 56, 5
  19. 19
    Matthew T. Kitson, Stuart K. Roberts, D-livering the message: The importance of vitamin D status in chronic liver disease, Journal of Hepatology, 2012, 57, 4, 897

    CrossRef

  20. 20
    C. Cooper, Hepatitis C Treatment Highlights From the 2011 American Association for the Study of Liver Disease Meeting, Clinical Infectious Diseases, 2012, 55, 3, 418

    CrossRef

  21. 21
    Monika Rau, Katharina Baur, Andreas Geier, Host Genetic Variants in the Pathogenesis of Hepatitis C, Viruses, 2012, 4, 12, 3281

    CrossRef

  22. 22
    K. Lind, M. H. Hühn, M. Flodström-Tullberg, Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes, Clinical & Experimental Immunology, 2012, 168, 1
  23. 23
    Midori Takeda, Masanori Ikeda, Kyoko Mori, Masahiko Yano, Yasuo Ariumi, Hiromichi Dansako, Takaji Wakita, Nobuyuki Kato, Raloxifene inhibits hepatitis C virus infection and replication, FEBS Open Bio, 2012, 2, 279

    CrossRef

  24. 24
    Qianqian Zhu, Na Li, Qunying Han, Zhu Li, Guoyu Zhang, Fang Li, Pingping Zhang, Jinghong Chen, Yi Lv, Zhengwen Liu, Single-Nucleotide Polymorphism atCYP27B1-1260, but NotVDR TaqI, Is Possibly Associated with Persistent Hepatitis B Virus Infection, Genetic Testing and Molecular Biomarkers, 2012, 16, 9, 1115

    CrossRef

  25. 25
    Henry Puerta-Guardo, Sergio Isaac De la Cruz Hernández, Victor H. Rosales, Juan E. Ludert, Rosa María del Angel, The 1α,25-dihydroxy-vitamin D3 reduces dengue virus infection in human myelomonocyte (U937) and hepatic (Huh-7) cell lines and cytokine production in the infected monocytes, Antiviral Research, 2012, 94, 1, 57

    CrossRef

  26. You have full text access to this OnlineOpen article26
    Edmondo Falleti, Davide Bitetto, Carlo Fabris, Giovanna Fattovich, Annarosa Cussigh, Sara Cmet, Elisa Ceriani, Ezio Fornasiere, Michela Pasino, Donatella Ieluzzi, Mario Pirisi, Pierluigi Toniutto, Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C, Hepatology, 2012, 56, 5
  27. 27
    Hans L Tillmann, Vitamins? The magic bullet against hepatitis C, Expert Review of Anti-infective Therapy, 2012, 10, 11, 1273

    CrossRef